Advisory Research Inc Treace Medical Concepts, Inc. Transaction History

Advisory Research Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$23.91 - $27.81 $30,413 - $35,374	1,272 Added 11.8%	12,056 $308,000
Q1 2023 May 12, 2023	SELL	$20.23 - $26.22 $729,493 - $945,493	-36,060 Reduced 76.98%	10,784 $271,000
Q4 2022 Feb 13, 2023	SELL	$20.54 - $24.67 $1.35 Million - $1.62 Million	-65,501 Reduced 58.3%	46,844 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$14.71 - $24.18 $1.65 Million - $2.72 Million	112,345 New	112,345 $2.48 Million

140

40.6M

352K

269K

Ticker TMCI
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 55,403,300
Market Cap $544M
Description
Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...

Get notified when there are updates to the investment portfolio of Advisory Research Inc, based on Form 13F filings with the SEC.

Stay updated on Advisory Research Inc with notifications on news.